Review of fibromyalgia treatment guidelines: part 2 – pharmacological treatment

Abstract Fibromyalgia is a complex condition characterized by widespread chronic pain, fatigue, and sleep disturbances, which significantly affect quality of life. Its pathophysiology involves central sensitization (CS) and changes in neurotransmitters. Management is challenging and requires a multi...

詳細記述

書誌詳細

主要な著者:	Roberto Ezequiel Heymann, Marcelo Cruz Rezende, Eduardo dos Santos Paiva, Marcos Renato de Assis, Alessandra de Sousa Braz, Aline Ranzolin, Ana Paula Monteiro Gomides Reis, Andrea Pimentel Fonseca Golmia, Anna Beatriz Assad Maia, Denison Santos Silva, Fernando Augusto Chiuchetta, Gabriela Galassi, Izabela Guimarães, José Eduardo Martinez, José Roberto Provenza, Juliana Maria de Freitas Trindade Costa, Marcos Paulo Veloso Correia, Marco Antônio Gonçalves Pontes Filho, Marco Aurelio Goldenfum, Marcos Aurelio de Freitas Machado, Melissa Mariti Fraga, Nilton Salles Rosa Neto, Rafael Navarrete Fernandez, Member of the Pain Committee of the Brazilian Society of Rheumatology
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2026-01-01
シリーズ:	Advances in Rheumatology
主題:	Fibromyalgia Chronic pain Central sensitization Guidelines Pharmacological treatment Duloxetine
オンライン･アクセス:	https://doi.org/10.1186/s42358-025-00483-2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!